19 reports

ONE UNIT REFERS TO ONE PROBE.

  • Endoscopic Device
  • East Asia
  • South Korea
  • Market Size
  • CareDx, Inc.

ONE UNIT REFERS TO ONE PROBE.

  • Endoscopic Device
  • Northern Europe
  • United Kingdom
  • Market Size
  • LiDCO Group Plc

The interest in echinacea has been strongly suppressed by the development of antiviral OTC drugs like Kagotsel.

  • Ophthalmic Solution
  • OTC
  • Russia
  • Demand
  • GlaxoSmithKline plc

The two-invoice system regulates the market by only allowing one invoice from the manufacturer to the distributor, and one invoice from the distributor to the hospital.

  • Ophthalmic Solution
  • OTC
  • Pharmaceutical
  • China
  • Demand

Television advertising is one of the most popular channels for promotion by companies.

  • Ophthalmic Solution
  • Ukraine
  • Demand
  • Forecast
  • GlaxoSmithKline plc
  • Enhancing its eye care portfolio Establishing strategic alliances and collaborations
  • Vendor landscape

It begins in one eye and spreads to the other.

  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated

Both of these switches are proposed for ## October 2019.

  • Ophthalmic Solution
  • Australia
  • Demand
  • Sanofi S.A.
  • Swisse Wellness Group Pty Ltd

One unit refers to one dura substitute.

  • Endoscopic Device
  • Health Services
  • Germany
  • Company
  • Market Segment

One unit refers to one dura substitute.

  • Endoscopic Device
  • Ophthalmic Solution
  • United States
  • Company
  • Stryker Corporation

ONE UNIT REFERS TO ONE CLIP.

  • Endoscopic Device
  • Hospital
  • Germany
  • Western Europe
  • Stryker Corporation

ONE UNIT REFERS TO ONE PROBE.

  • Endoscopic Device
  • Healthcare IT
  • Medical Device
  • Ophthalmic Solution
  • Patient Monitoring
  • Feb 04, 2019: Okogen starts Phase II OKG-0301 trial for adenoviral conjunctivitis
  • CLINICAL TRIAL PROFILE SNAPSHOTS

OKG-## is a topical ophthalmic formulation of ranpirnase, a ribonuclease (RNase) that contains broad-spectrum antiviral properties.

  • Ophthalmic Solution
  • OTC
  • Therapy
  • World
  • Product Initiative

One unit refers to one dura substitute.

  • Endoscopic Device
  • United Kingdom
  • Company
  • Market Segment
  • Medtronic, Inc.

MYRCLUDEX HAS SHOWN AN EXCELLENT SAFETY PROFILE AND ANTIVIRAL EFFICACY IN SEVERAL CLINICAL TRIALS.

  • Endoscopic Device
  • Hospital
  • Medical Device
  • Ophthalmic Solution
  • Market Size

One unit refers to one clip.

  • Endoscopic Device
  • Neurological Disorder
  • Neurology
  • Neuromodulation Device
  • AorTech International plc
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • World

One unit refers to one A - scan.

  • Endoscopic Device
  • Healthcare
  • Ophthalmic Solution
  • North America
  • United States

IT USUALLY AFFECTS ONLY ONE EYE.

  • Ophthalmic Solution
  • Alcon, Inc.
  • Allergan plc
  • Merck & Co., Inc.
  • Novartis AG

ALCON IS CONTINUING TO EVALUATE OPTIONS TO ACQUIRE ZIRGAN(TM), AN ANTIVIRAL RECENTLY APPROVED BY THE FDA FOR THE TREATMENT OF ACUTE HERPETIC KERATITIS (CORNEAL ULCERS).

  • Ophthalmic Solution
  • United States
  • Company
  • M&A
  • Alcon, Inc.